Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-bromo-a-23187

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-bromo-a-23187 in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(4-bromo-a-23187)
Trials
(4-bromo-a-23187)
Recent Studies (post-2010) (4-bromo-a-23187)
9,1561875526305

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melder, DC; Olsen, RA; Powis, G; Schlager, JJ; Seewald, MJ1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-bromo-a-23187

ArticleYear
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.
    Cancer communications, 1989, Volume: 1, Issue:3

    Topics: Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Bradykinin; Calcimycin; Calcium; Cells, Cultured; Dextran Sulfate; Dextrans; Fibroblasts; Guanosine Triphosphate; Halothane; Heparin; Inositol 1,4,5-Trisphosphate; Mitogens; Molecular Weight; Platelet Activating Factor; Receptors, Cell Surface

1989